Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hunt

Showing results (791-800 of 1,059) with videos related to

Pageof 106
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 22, 2010
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomyMin Yi, Kelly K Hunt, Banu K Arun, et al.
Annals of Surgical Oncology|September 26, 2008
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patientsElizabeth A Mittendorf, Aysegul A Sahin, Susan L Tucker, et al.
Breast Cancer Research : BCR|May 25, 2012
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapyAbigail S Caudle, Tse-Kuan Yu, Susan L Tucker, et al.
Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.
Annals of Surgery|September 30, 2005
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancerKatherine E Posther, Linda M McCall, Peter W Blumencranz, et al.
Annals of Surgical Oncology|July 10, 2012
The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancerRosalinda Alvarado, Min Yi, Huong Le-Petross, et al.
Breast Cancer Research and Treatment|February 19, 2011
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancersT R Lester, K K Hunt, K M Nayeemuddin, et al.
Oncogenesis|May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancersAmriti R Lulla, Said Akli, Cansu Karakas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2014
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatmentAndrew McBride, Pamela Allen, Wendy Woodward, et al.
Annals of Surgical Oncology|August 18, 2004
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapyJeannie Shen, Vicente Valero, Thomas A Buchholz, et al.
Pageof 106

Showing results (791-800 of 1,059) with videos related to

Sort By:
Pageof 106
Cancer Prevention Research (Philadelphia, Pa.)|July 22, 2010
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomyMin Yi, Kelly K Hunt, Banu K Arun, et al.
Annals of Surgical Oncology|September 26, 2008
Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patientsElizabeth A Mittendorf, Aysegul A Sahin, Susan L Tucker, et al.
Breast Cancer Research : BCR|May 25, 2012
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapyAbigail S Caudle, Tse-Kuan Yu, Susan L Tucker, et al.
Cancer|April 19, 2012
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancerMichelle M Kim, Shaheenah Dawood, Pamela Allen, et al.
Annals of Surgery|September 30, 2005
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancerKatherine E Posther, Linda M McCall, Peter W Blumencranz, et al.
Annals of Surgical Oncology|July 10, 2012
The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancerRosalinda Alvarado, Min Yi, Huong Le-Petross, et al.
Breast Cancer Research and Treatment|February 19, 2011
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancersT R Lester, K K Hunt, K M Nayeemuddin, et al.
Oncogenesis|May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancersAmriti R Lulla, Said Akli, Cansu Karakas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 12, 2014
Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatmentAndrew McBride, Pamela Allen, Wendy Woodward, et al.
Annals of Surgical Oncology|August 18, 2004
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapyJeannie Shen, Vicente Valero, Thomas A Buchholz, et al.
Pageof 106